CSPC Pharmaceutical Group (FRA:CVGU) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
CSPC Pharmaceutical Group EBITDA Margin % Related Terms
CSPC Pharmaceutical Group EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CVGU vs LLY, JNJ, ABBV: EBITDA Margin % Comparison
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (FRA:CVGU) has a EBITDA Margin % of 31.48% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CSPC Pharmaceutical Group and its competitors. This is 18% above median its historical median of 26.76. Over the past decade, CSPC Pharmaceutical Group's EBITDA Margin % has ranged from 21.99 to 28.92. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #259 out of 955 companies in the Drug Manufacturers industry, placing it in the top 27.1%.
Is CSPC Pharmaceutical Group's EBITDA Margin % too high?
CSPC Pharmaceutical Group's current EBITDA Margin % of 31.48% is 18% above median its 10-year median of 26.76. Over the past 10 years, this metric has ranged from a low of 21.99 to a high of 28.92. The Drug Manufacturers industry median EBITDA Margin % is 12.39. CSPC Pharmaceutical Group's value of 31.48% is 154.1% above this industry median. Based on the distribution chart, CSPC Pharmaceutical Group ranks #259 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, CSPC Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's EBITDA Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #259 out of 955 companies for EBITDA Margin %. This puts CSPC Pharmaceutical Group in the upper half of its industry. The industry median EBITDA Margin % is 12.39. CSPC Pharmaceutical Group's value of 31.48% is 154.1% above this benchmark. Historically, CSPC Pharmaceutical Group's own EBITDA Margin % has ranged from 21.99 to 28.92 over the past decade. While the company's 10-year median is 26.76 vs. the industry median of 12.39, CSPC Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSPC Pharmaceutical Group's current EBITDA Margin % of 31.48% is 154.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current EBITDA Margin % is 31.48%, which is 18% above median its own 10-year median of 26.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
CSPC Pharmaceutical Group (FRA:CVGU) has a current EBITDA Margin % of 31.48%. The stock's GF Value™ is €2.72, compared to a current price of €2.74 — trading 0.7% above its estimated fair value. The current EBITDA Margin % is 31.48%, which is 18% above median its 10-year median of 26.76 and 154.1% above the Drug Manufacturers industry median of 12.39. CSPC Pharmaceutical Group's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For CSPC Pharmaceutical Group (FRA:CVGU), the current EBITDA Margin % is 31.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSPC Pharmaceutical Group (FRA:CVGU) Overvalued in 2026?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued.
The current stock price of €2.74 is trading 0.7% above its estimated GF Value™ of €2.72.
Key valuation signals for FRA:CVGU:
EBITDA Margin %: 31.48% (18% above median its 10-year median of 26.76)
GF Value™: €2.72 vs. price of €2.74 (0.7% above fair value)
Industry Position: 154.1% above the Drug Manufacturers median (#259 of 955)
No single metric tells the full story. See the FRA:CVGU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
88GF Score
Get the complete analysis for FRA:CVGU
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CVGU has been successfully added to your 
